{"id":4075,"company":{"country":"KY","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2014-05-16","marketCap":486.3322448730469,"name":"Theravance Biopharma Inc","phone":"16508086000","outstanding":48.630001068115234,"symbol":"TBPH","website":"https://www.theravance.com/","industry":"Pharmaceuticals"},"price":10.065,"year":2024,"month":7,"day":25,"weekday":"Thursday","title":"Impact of Currency Fluctuations on Theravance Biopharma Inc","date":"2024-07-25","url":"/posts/2024/07/25/TBPH","content":[{"section":"Introduction","text":"Theravance Biopharma Inc is a multinational company that operates in various countries and holds investments in foreign subsidiaries. As a result, it is exposed to currency fluctuations, which can significantly impact its stock performance."},{"section":"Positive Impact","text":"Currency fluctuations can sometimes have a positive impact on Theravance Biopharma Inc's stock. When the company's functional currency is stronger than the reporting currency, the translation of foreign earnings into the reporting currency increases. This can lead to higher reported revenues and profitability, thus positively influencing investor sentiment and potentially boosting stock prices."},{"section":"Case Study: Strengthening US Dollar","text":"In a scenario where the US dollar strengthens against other currencies, Theravance Biopharma Inc, with its primary functional currency being the US dollar, would benefit from the translation effect. For example, if the Euro weakens against the US dollar, the reported revenues and profitability of Theravance Biopharma's European subsidiary increase when translated into US dollars. This positive impact on financial statements can attract investors and positively affect the company's stock price."},{"section":"Negative Impact","text":"On the other hand, currency fluctuations can also have a negative impact on Theravance Biopharma Inc's stock. If the functional currency weakens against the reporting currency, the translation of foreign earnings into the reporting currency decreases. This could lead to lower reported revenues and profitability, potentially dampening investor sentiment and causing stock prices to decline."},{"section":"Case Study: Weakening British Pound","text":"Consider a scenario where Theravance Biopharma Inc's British subsidiary generates significant earnings in British pounds. If the British pound weakens against the US dollar, the translation of those earnings into US dollars would decrease. This could result in lower reported profits and potentially a negative impact on the company's stock price."},{"section":"Balanced Assessment of Currency Risk","text":"Currency risk is inherent in multinational operations, and Theravance Biopharma Inc is no exception. While currency fluctuations can have both positive and negative effects on the company's stock, it is important to note that they are often beyond the company's control. These risks can be mitigated to some extent through hedging strategies, such as forward contracts and options, to minimize the impact of adverse currency movements. Additionally, the company's overall financial health, product pipeline, and market positioning also play crucial roles in determining stock performance, mitigating the sole focus on currency risk."},{"section":"Conclusion","text":"Currency fluctuations can significantly impact Theravance Biopharma Inc's multinational stock. While a stronger functional currency can lead to increased reported revenues and profitability, a weaker functional currency can result in lower reported figures. Considering currency risk as a part of the broader risk management strategy is essential for investors and the company alike."}],"tags":["CrossOver21","Long","Pharmaceuticals"],"news":[{"category":"company","date":1721887276,"headline":"Theravance Biopharma to Participate in an Upcoming Investor Conference","id":128903386,"image":"","symbol":"TBPH","publisher":"Finnhub","summary":"DUBLIN, July 25, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Tuesday, August 6 at 12:00 pm ET . Members of...","url":"https://finnhub.io/api/news?id=e7ffc8bcccfe08a3486e11e6eff8a483fe8bef105b0e4e1441543e8f81c3830c"},{"category":"company","date":1721821116,"headline":"Theravance Biopharma, Inc. (NASDAQ:TBPH): When Will It Breakeven?","id":128882967,"image":"https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","symbol":"TBPH","publisher":"Yahoo","summary":"Theravance Biopharma, Inc. ( NASDAQ:TBPH ) is possibly approaching a major achievement in its business, so we would...","url":"https://finance.yahoo.com/news/theravance-biopharma-inc-nasdaq-tbph-113836810.html"},{"category":"company","date":1721642400,"headline":"Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024","id":128829592,"image":"https://media.zenfs.com/en/prnewswire.com/4d2df003249986704ef2ebec0198a9bd","symbol":"TBPH","publisher":"Yahoo","summary":"Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its second quarter 2024 financial results and provide a business update after market close on Monday, August 5, 2024. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm ET (2:00 pm PT/10:00 pm IST) that day.","url":"https://finance.yahoo.com/news/theravance-biopharma-report-second-quarter-100000355.html"},{"category":"company","date":1721296980,"headline":"Biotech Alert: Searches spiking for these stocks today","id":128761198,"image":"","symbol":"TBPH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3562365945"},{"category":"company","date":1721052900,"headline":"Best Momentum Stocks to Buy for July 15th","id":128700979,"image":"https://media.zenfs.com/en/zacks.com/22d93c77b91a36ccc2d6a44613af467e","symbol":"TBPH","publisher":"Yahoo","summary":"TBPH, HGV, and SPT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 15, 2024.","url":"https://finance.yahoo.com/news/best-momentum-stocks-buy-july-141500451.html"}]}